| Literature DB >> 33926066 |
Wan-Hsiang Hu1,2, Wen-Chi Yang3,4, Pei-Feng Liu5,6, Ting-Ting Liu7,8, Paul Morgan4, Wei-Lun Tsai9,10, Hung-Wei Pan4, Cheng-Hsin Lee5, Chih-Wen Shu5,11.
Abstract
Gene mutation and pathogenesis bacteria are highly associated with colorectal cancer (CRC) development and progression. Autophagy is a self-clearance pathway to degrade abnormal proteins and infected bacteria in cells. Autophagy plays a dual role in cancer development. Among the autophagy-related (ATG) proteins, ATG5 is the key component required for the core machinery of autophagy. However, the role of ATG5 in CRC malignancy remains unclear. Herein, we found that a high ATG5 protein level was correlated with poor overall survival (OS) and disease-free survival (DFS) of 118 patients with CRC. After stratification with demographic and clinicopathologic factors, a high ATG5 protein level was significantly correlated with unfavorable overall survival in female and elder (>60 year) CRC patients and tumor tissues with poor differentiation, late T stages (III + IV), whereas the ATG5 protein level was positively associated with the overall survival in CRC patients without lymph node invasion and radiation therapy. In contrast, a high ATG5 protein level was significantly associated with worse DFS in CRC patients with early stage of AJCC and no radiation therapy. In addition, colorectal cancer cells stably harboring small interfering RNA (siRNA) against ATG5 diminished the tumorsphere formation and sensitized cancer cells to chemotherapeutic agents. Taken together, our results suggest that ATG5 might be a prognostic biomarker for CRC and a potential therapeutic target for CRC patients.Entities:
Keywords: ATG5; autophagy; colorectal cancer; prognosis
Year: 2021 PMID: 33926066 DOI: 10.3390/diagnostics11050782
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418